Cardinal Health, Inc. vs The Walt Disney Company: Strategic Comparison

This in-depth comparison examines Cardinal Health, Inc. and The Walt Disney Company across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Cardinal Health, Inc. on its own, evaluating The Walt Disney Company, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Cardinal Health, Inc. and The Walt Disney Company is widest.

On the headline numbers, Cardinal Health, Inc. reports annual revenue of $254.2B against $94.4B for The Walt Disney Company, while their respective market capitalizations stand at $56.0B and $180.0B. Both Cardinal Health, Inc. and The Walt Disney Company are headquartered in United States, so they compete in a shared home market and regulatory environment.

Cardinal Health, Inc.: Cardinal Health, based in Ohio, is one of the three large US pharmaceutical distributors, along with McKesson and Cencora. It does not invent drugs or treat patients. It runs the regulated supply chain that moves medicines and medical devices from manufacturers to pharmacies and hospitals, so a prescription collected at a local pharmacy has often passed through its network.

The Walt Disney Company: The Walt Disney Company is one of the world's largest entertainment companies by revenue, with $94.4 billion in fiscal 2025 sales and about 231,000 employees. It owns Walt Disney Pictures, Pixar, Marvel Studios, Lucasfilm, 20th Century Studios, ABC, ESPN, Disney+, Hulu, six global park resort destinations (some operated or licensed with partners) and Disney Cruise Line. The company's economics have shifted: theme parks and cruises now generate most of its operating profit, streaming has moved from losses to profit, and traditional TV is shrinking. Josh D'Amaro, former head of Disney Experiences, succeeded Bob Iger as CEO on March 18, 2026.

Cardinal Health, Inc. and The Walt Disney Company pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Cardinal Health, Inc. and The Walt Disney Company.

Cardinal Health, Inc. business model: The business model is large, high-volume logistics divided into two segments: Pharmaceutical and Medical. In the Pharma segment, they buy billions of dollars of drugs from manufacturers (like Pfizer) and distribute them daily to tens of thousands of pharmacies and hospitals, taking a tiny markup. In the Medical segment, they actually manufacture and distribute low-cost, high-volume medical supplies (like surgical gloves, gowns, and syringes), acting as the large central supply closet for the entire American hospital system.

The Walt Disney Company business model: Disney reports three segments. Entertainment ($42.5B FY2025 revenue, $4.7B segment operating income) sells Disney+ and Hulu subscriptions and advertising, releases films theatrically, licenses content and runs ABC and cable networks. Sports ($17.7B revenue, $2.9B operating income) is mainly ESPN, which earns affiliate fees from pay-TV distributors, advertising and direct-to-consumer subscriptions. Experiences ($36.2B revenue, $10.0B operating income) covers Walt Disney World, Disneyland, Disney Cruise Line, international parks and consumer products licensing. Experiences produced roughly 57% of segment operating income in fiscal 2025, so the parks and cruises fund much of the content spending that keeps the franchises valuable. Disney has said much of consumer products will move into Entertainment starting in fiscal Q1 2027.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Cardinal Health, Inc. stack up against those of The Walt Disney Company.

Cardinal Health, Inc. competitive advantage: Cardinal Health's advantage is physical scale and regulatory standing. Moving regulated, temperature-sensitive drugs and biologics across the country overnight takes a network of specialized distribution centers and security procedures that cost billions of dollars and take decades to build. The barrier to entry is high, so drug distribution is concentrated among a few large companies.

The Walt Disney Company competitive advantage: Disney owns a franchise library that few rivals can match, including Mickey Mouse, Disney Animation, Pixar, Marvel, Star Wars, Avatar and The Simpsons, and it can monetize the same story through box office, Disney+, parks, cruises and licensing. Its parks are hard to copy because they need decades of land, capital and Imagineering know-how; Walt Disney World alone spans about 25,000 acres. ESPN gives Disney the deepest U.S. sports-rights portfolio of any traditional media company, including NFL, NBA and college football. The combination lets Disney recover content costs across more revenue streams than a pure streaming service can.

Future prospects matter as much as current results. The growth strategies below explain how Cardinal Health, Inc. and The Walt Disney Company each plan to expand from here.

Cardinal Health, Inc. growth strategy: Cardinal Health's growth plan rests on three levers. First, specialty pharmaceuticals and physician practice platforms: it bought a 71% stake in GI Alliance for about $2.8 billion (announced November 2024) and funded The Specialty Alliance's roughly $1.9 billion acquisition of urology MSO Solaris Health (completed November 2025). Second, the Other segment: Nuclear and Precision Health Solutions (radiopharmaceuticals and theranostics), at-Home Solutions (expanded with ADSG in 2025, Strive Medical, and the announced AdaptHealth diabetes business), and OptiFreight Logistics, which together grew revenue 26% to $6.8 billion in fiscal 2026. Third, improving GMPD profitability through its Cardinal Health brand products and cost actions.

The Walt Disney Company growth strategy: Under CEO Josh D'Amaro, Disney's plan centers on a 'One Disney' push to align its divisions around franchises, plus three investment priorities. First, streaming margins: Disney targeted a 10% operating margin for Entertainment DTC in fiscal 2026 through price increases, advertising tiers, password-sharing limits and the integrated Disney+ and Hulu app. Second, sports: ESPN launched its direct-to-consumer service in August 2025 and closed the deal for NFL Network and other NFL Media assets in early 2026, with the NFL taking a minority stake in ESPN. Third, Experiences capacity: a roughly $60 billion, 10-year parks and cruise investment plan, new ships including Disney Destiny and Disney Adventure, and a planned park in Abu Dhabi developed with Miral. Disney also raised its fiscal 2026 buyback target to at least $9 billion after agreeing to sell its 50% stake in A+E Global Media to Hearst for about $1.2 billion.

A closer look at the financial trajectory of Cardinal Health, Inc. and The Walt Disney Company rounds out the comparison.

Cardinal Health, Inc.: Cardinal Health combines very large revenue with thin margins. Fiscal 2026 revenue was $254.2 billion, up 14% from $222.6 billion in fiscal 2025, driven by brand and specialty drug volume from existing customers. GAAP operating earnings were $2.6 billion, GAAP diluted EPS was $7.23, and net earnings attributable to Cardinal Health were about $1.7 billion. Non-GAAP diluted EPS rose 37% to $11.26 ($10.95 excluding the IEEPA tariff refund). Operating cash flow was $5.2 billion and adjusted free cash flow was $5.0 billion. The company repurchased $1.4 billion of stock in fiscal 2026 and the board added $5.0 billion to the buyback authorization in August 2026. Fourth-quarter fiscal 2026 revenue was $63.7 billion, up 6%.

The Walt Disney Company: Disney's fiscal 2025 (ended September 27, 2025) revenue rose 3% to $94.4 billion, net income was $12.4 billion and adjusted EPS increased 19% to $5.93. Total segment operating income rose 12% to $17.6 billion, led by a record $10.0 billion from Experiences. Streaming became a reliable profit contributor after years of losses. In fiscal Q3 2026 (ended June 27, 2026), revenue grew 7% to $25.25 billion, Experiences revenue rose 10% to $9.97 billion, entertainment streaming revenue rose 11% to $5.53 billion, and adjusted EPS climbed to $2.06 from $1.61. Management guided to $9 billion of fiscal 2026 capital spending, about $24 billion of content investment and at least $9 billion of share repurchases.